Abstract
The SARS-CoV-2 infection, known as COVID-19, has caused millions of deaths worldwide. In the survivors of this disease, cardiovascular symptoms can be observed until 12 months after the diagnosis, in the post-COVID phase. It has been suggested that microparticles (MP) could contribute to worsening the COVID-19 in the long term. These extracellular vesicles have the ability to carry bioact…